Acute administration of T3 or rT3 failed to improve outcome following resuscitation from cardiac arrest in dogs

Resuscitation

Volumn 33, Issue 1, 1996, Pages 53-62

  Whitesall, Steven E ^a   Mayor, Gilbert H ^b   Nachreiner, Ray F ^c   Zwemer, Charles F ^a   D'Alecy, Louis G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Knoll Pharmaceuticals   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Global cerebral ischemia; Levothyroxine sodium; Low serum thyroid hormone concentration; Neurologic deficit; Reverse triiodothyronine; Triiodothyronine

Indexed keywords

LEVOTHYROXINE SODIUM; LIOTHYRONINE; RECOMBINANT PROTEIN; THYROID HORMONE; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOG; HEART ARREST; HEART VENTRICLE FIBRILLATION; HORMONE SUBSTITUTION; LIOTHYRONINE BLOOD LEVEL; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESUSCITATION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; DOGS; HEART ARREST; MALE; NEUROLOGIC EXAMINATION; RADIOIMMUNOASSAY; RESUSCITATION; THYROXINE; TIME FACTORS; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 0030297149     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(96)00985-9     Document Type: Article

References (57)

1. [1] Wortsman J, Premachandra BN, Chopra IJ, Murphy JE. Hypothyroxinemia in cardiac arrest. Arch Intern Med 1987; 147: 245-248.
2. [2] Chopra IJ, Solomon DH, Hepner GW, Morgenstein AA. Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann Intern Med 1979; 90: 905-912.
3. [3] Faber J, Kirkegaard C, Lumholtz IB, Siersbaek-Nielsen K, Friis T, Variations in serum T3, rT3, 3,3′-diiodothyronine and 3′,5′-diiodothyronine induced by acute myocardial infarction and propranolol. Acta Endocrinol 1980; 94: 341-345.
4. [4] Wiersinga WM, Lie KI, Touber JL. Thyroid hormones in acute myocardial infarction. Clin Endocrinol 1981; 14: 367-374.
5. [5] Kahana L, Keidar S, Sheinfeld M, Palant A. Endogenous cortisol and thyroid hormone levels in patients with acute myocardial infarction. Clin Endocrinol 1983; 19: 131-139.
6. [6] Franklyn JA, Gammage MD, Ramsden DB, Sheppard MC. Thyroid status in patients after acute myocardial infarction. Clin Sci 1984; 67: 585-590.
7. [7] Novitzky D, Matthews N, Shawley D, Cooper DK, Zuhdi N. Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg 1991; 51: 10-17.
8. [8] Baue AE, Günther B, Hartel W, Ackenheil M, Heberer G. Altered hormonal activity in severely ill patients after injury or sepsis. Arch Surg 1984; 119: 1125-1132.
9. [9] Zaloga GP, Chernow B, Smallridge RC, Zajtchuk R, Hall-Boyer K, Hargraves R, Lake CR, Burman KD. A longitudinal evaluation of thyroid function in critically ill surgical patients. Ann Surg 1985; 201 (4): 456-464.
10. [10] Robuschi G, Medici D, Fesani F, Barboso G, Montermini M, d'Amato L, Gardini E, Borciani E, Dall'Aglio E, Salvi M, Gnudi A, Roti E. Cardiopulmonary bypass: 'a low T4 and T3 syndrome' with blunted thyrotropin (TSH) response to thyrotropin releasing hormone (TRH). Horm Res 1986; 23: 151-158.
11. [11] Novitzky D, Human PA, Cooper DKC. Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988; 96: 600-607.
12. [12] Novitzky D, Human PA, Cooper DKC. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann Thorac Surg 1988; 45: 50-55.
13. [13] Holland FW, Brown PS, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a 'euthyroid sick syndrome? Ann Thorac Surg 1991; 52: 46-50.
14. [14] Novitzky D, Wicomb WN, Cooper DKC, Rose AG, Fraser RC, Barnard CN. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the chacma baboon. Heart Transplant 1984; 4: 63-69.
15. [15] Novitzky D, Cooper DKC, Morrell D, Isaacs S. Brain death, triiodothyronine depletion, and inhibition of oxidative phosphorylation: relevance to management of organ donors. Transplant Proc 1987; 19 (5): 4110-4111.
16. [16] Novitzky D, Cooper DKC, Wicomb WN. Endocrine changes and metabolic responses. Transplant Proc 1988; 20 (5 Suppl 7): 33-38.
17. [17] Robertson KM, Hramiak IM, Gelb AW. Endocrine changes and hemodynamic stability after brain death. Transplant Proc 1989; 21: 1197-1198.
18. [18] Masson F, Thicoipe M, Latapie MJ, Maurette P. Thyroid function in brain-dead donors. Transplant Int 1990; 3: 226-233.
19. [19] Sazontseva IE, Kozlov IA, Moisuc YG, Ermolenko AE, Afonin VV, Ilnitsky VV. Hormonal response to brain death. Transplant Proc 1991; 23: 2467.
20. [20] Huber TS, Nachreiner RF, D'Alecy LG. Hormonal profiles in a canine model of the brain dead organ donor. J Crit Care 1994; 9(1): 7-17.
21. [21] Novitzky D, Cooper DKC, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43: 852-854.
22. [22] Novitzky D, Wicomb WN, Cooper DKC, Tjaalgard MA. Improved cardiac function following hormonal therapy in brain dead pigs: relevance to organ donation. Cryobiology 1987; 24: 1-10.
23. [23] Novitzky D, Cooper DKC. Results of hormonal therapy in human brain-dead potential organ donors. Transplant Proc 1988; 20 (5)suppl. 7: 59-62.
24. [24] Novitzky D, Cooper DKC, Chaffin JS, Greer AE, DeBault LE, Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990; 49: 311-316.
25. [25] Novitzky D. Triiodothyronine replacement, the euthyroid sick syndrome, and organ transplant. Transplant Proc 1991; 23: 2460-2462.
26. [26] Pienaar H, Schwartz I, Roncone A, Lotz Z, Hickman R. Function of kidney grafts from brain-dead donor pigs. Transplantation 1990; 50: 580-582.
27. [27] Garcia-Fages LC, Antolin M, Cabrer C, Talbot R, Alcaraz A, Lozano F, Manyalich M. Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs. Transplant Proc 1991; 23: 2495-2496.
28. [28] Facktor MA, Mayor GH, Nachreiner RF, D'Alecy LG. Thyroid hormone loss and replacement during resuscitation from cardiac arrest in dogs. Resuscitation 1993; 26: 141-162.
29. [29] Nachremer RF, Refsal KR, Ravis WR, Hauptman J, Rosser EJ, Pdersoli WM. The pharmacokinetics of L-thyroxine in dogs after oral administration. Am J Vet Res 1993; 54 (12): 2091-2098.
30. [30] Bronk JR. Thyroid hormones: control of terminal oxidation. Science 1963; 141: 816-818.
31. [31] Bronk JR, Bronk SB. The influence of thyroxine on oxidative phosphorylation in mitrochondria from thyroidectomized rats. J Biol Chem 1962; 237 (3): 897-903.
32. [32] Dallam RD, Howard RB. Thyroxine-enhanced oxidative phosphorylation of rat-liver mitochondria. Biochim Biophys Acta 1960; 37: 188.
33. [33] Sokoloff L, Kaufman S, Campbell PL, Francis CM, Gelboin HV. Thyroxine stimulation of amino acid incorporation into protein. J Biol Chem 1963; 238: 1432.
34. [34] Campbell PL, Deibler GE, Gelber S, Sokoloff L. Comparative effects of various analogues of thyroxine on amino acid incorporation into protein. Endocrinology 1964; 75: 304.
35. [35] Sokoloff L, Roberts PA, Januska MM, Kline JE. Mechanisms of stimulation of protein synthesis by thyroid hormones in vivo. Proc Natl Acad Sci USA 1968; 60: 652.
36. [36] D'Alecy LG, Lundy EF, Barton KJ, Zelenock GB. Dextrose containing intravenous fluid impairs outcome and increases death after eight minutes of cardiac arrest and resuscitation in dogs. Surgery 1986; 100: 505-511.
37. [37] Kuhn JE, Steimle CN, Zelenock GB, D'Alecy LG. Ibuprofen improves survival and neurologic outcome after resuscitation from cardiac arrest. Resuscitation 1986; 14: 199-212.
38. [38] Lundy EF, Kuhn JE, Kwon JM, Zelenock GB, D'Alecy LG. Infusion of five percent dextrose increases mortality and morbidity following six minutes of cardiac arrest in resuscitated dogs. J Crit Care 1987; 2 (1): 4-14.
39. [39] Natale JE, Schott RJ, Hall ED, Braughler JM, D'Alecy LG. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988; 19: 1371-1378.
40. [40] Natale JE, D'Alecy LG. Protection from cerebral ischemia by brain cooling without reduced lactate accumulation in dogs. Stroke 1989; 20: 770-777.
41. [41] Natale JE, D'Alecy LG, Continued circulatory support: effect of epinephrine or dopamine on 24-h survival and neurologic function in dogs. Resuscitation 1989; 17: 273-286.
42. [42] Schott RJ, Natale JE, Ressler SW, Burney RE, D'Alecy LG. Neutrophil depletion fails to improve neurologic outcome after cardiac arrest in dogs. Ann Emerg Med 1989; 18: 517-522.
43. [43] Natale JE, Stante SM, D'Alecy LG. Elevated brain lactate accumulation and increased neurologic deficit are associated with modest hyperglycemia in global brain ischemia. Resuscitation 1990; 19: 271-289.
44. [44] Zwemer CF, Whitesall SE, D'Alecy LG. Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of normothermic cardiac arrest in dogs. Resuscitation 1994; 27: 159-170.
45. [45] Zwemer CF, Whitesall SE, D'Alecy LG. Hypoxic cardiopulmonary-cerebral resuscitation fails to improve neurologic outcome following cardiac arrest. Resuscitation 1995; 29: 225-236.
46. [46] Nachreiner RF, Forsberg M, Johnson CA et al. Validation of an assay for canine TSH (cTSH). ACVIM 13th Annual Forum, Orlando, Florida, USA 1995, A17 [abstract].
47. [47] Reichert LE. On the relationship between human thyrotrophin research standard A, the United States Pharmacopeia thyrotrophin standard (bovine) and the international standard for thyrotrophin. J Clin Endocrinol Metab 1970; 31: 330.
48. [48] Chopra IJ. A study of extrathyroidal conversion of thyroxine (T4) to 3,3′,5-triiodothyronine (T3) in vitro. Endocrinology 1977; 101: 453-463.
49. [49] Zwemer CF, Whitesall SE, Mayor GH, Nachreiner RF, D'Alecy LG. Acute thyroid hormone administration increases systemic oxygen delivery and consumption immediately following resuscitation from cardiac arrest without changes in TSH. Resuscitation 1997; in press.
50. [50] Lindner KH, Strohmenger HU, Prengel AW et al. Hemodynamic and metabolic effects of epinephrine during cardiopulmonary resuscitation in a pig model. Crit Care Med 1992; 20: 1020-1026.
51. [51] Lindner KH, Prengel AW, Ahnefeld FW et al. Effects of ditiazem on oxygen delivery and consumption after asphyxial cardiac arrest and resuscitation. Crit Care Med 1992; 20 (5): 650-658.
52. [52] Schindler I, Steltzer H, Weindlmayr-Goettel M et al. Nimodipine after circulatory arrest: effects on oxygen delivery and consumption. J Crit Care 1994; 9 (1): 18-24.
53. [53] Shoemaker WC, Appel PL, Bland R et al. Clinical trial of an algorithm for outcome prediction in acute circulatory failure. Crit Care Med 1982; 10 (6): 390-397.
54. [54] Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63 (1): 1-8.
55. [55] Becker RA, Vaughan GM, Ziegler MG, Seraile LG, Goldfarb IW, Mansour EH, McManus WF, Pruitt BA, Manson AD. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982; 10 (12): 870-875
56. [56] Lim VS, Tsalikian E, Flanigan MJ. Augmentation of protein degradation by L-triiodothyronine in uremia. Metabolism 1989; 38 (12): 1210-1215.
57. [57] Gardner DF, Kaplan MM, Stanely CA, Utiger RD. Effect of tri-iodothyronine replacement of the metabolic and pituitary responses to starvation. N Engl J Med 1979; 300 (11): 579-584.